ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 23-28)
DOI: 10.4318/tjg.2010.0043
Sequential therapy for Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 206-211)
DOI: 10.4318/tjg.2010.0089
Efficacy of probiotics in Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2010; 21: 212-217)
DOI: 10.4318/tjg.2010.0090
Effectiveness of different treatment regimens in helicobacter pylori eradication: Ten-year experience of a single institution
(Turk J Gastroenterol 2010; 21: 218-223)
DOI: 10.4318/tjg.2010.0091
Recurrence rates after Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 154-158)
The comparsion of lansoprazole and omeprazole in the one-week triple therapy for the eradication of Helicobacter Pylori
(Turk J Gastroenterol 1998; 9: 354-357)
Bismuth-based therapies for the first step eradication of Helicobacter pylori
(Turk J Gastroenterol 2006; 17: 90-93)
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis
(Turk J Gastroenterol 2006; 17: 172-176)
Efficacy of combination therapy with omeprazole, amoxicillin and clarithromycin for treatment of patients with Helicobacter pylori associated gastritis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 27-31)
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
(Turk J Gastroenterol 2005; 16: 29-33)
Turkish patients with osteoarthritis: Their awareness of the side effects of NSAIDs
(Turk J Gastroenterol 2005; 16: 89-92)
Characteristics of gastroesophageal reflux disease in our country
(Turk J Gastroenterol 1999; 10: 101-106)
Helicobacter pylori density in patients with nonulcer dyspepsia and patients with duodenal ulcer
(Turk J Gastroenterol 1999; 10: 407-410)
A comparison of lansoprazole and omeprazole based triple combinations for the treatment of Helicobacter pylori associated gastritis and peptic ulcer
(Turk J Gastroenterol 2000; 11: 25-29)
The effect of CagA status on response to Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2000; 11: 146-149)
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy
(Turk J Gastroenterol 2004; 15: 90-93)
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests
(Turk J Gastroenterol 2004; 15: 159-163)
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori
(Turk J Gastroenterol 2004; 15: 219-224)
Can resistant Helicobacter pylori infection be estimated histologically: Effects of gastric histology on eradication rates of Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 126-129)
The effect of Helicobacter pylori eradication on symptoms and gastric emptying in patients with nonulcer dyspepsia
(Turk J Gastroenterol 2002; 13: 146-153)
An effective and economic approach for the eradication of Helicobacter Pylori:omeprazole and two antibiotic combination
(Turk J Gastroenterol 1996; 7: 228-232)
Prevelance of helicobacter pylori infection among Turkish living in or near Stutgart Germany, and the effect of triple therapy (pantoprazole-clarithomycin-metronidzole) on Helicobacter pylori infection
(Turk J Gastroenterol 1996; 7: 237-239)
Predictors of vitamin B-12 deficiency: Age and helicobacter pylori load of antral mucosa
(Turk J Gastroenterol 2003; 14: 44-49)
Original Article
The diagnostic value of endoscopic narrow band imaging in helicobacter pylori gastritis in children
(Turk J Gastroenterol 2015; 26: 112-116)
DOI: 10.5152/tjg.2015.6717
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children
(Turk J Gastroenterol 2014; 25: 99-103)
DOI: 10.5152/tjg.2014.5592
Diagnosis and treatment of Helicobacter pylori for peptic ulcer bleeding in clinical practice - factors associated with non-diagnosis and non-treatment, and diagnostic yield in various settings
(Turk J Gastroenterol 2014; 25: 157-161)
DOI: 10.5152/tjg.2014.3843
The cytokine response in THP-1 (monocyte) and HL-60 (neutrophil-differentiated) cells infected with different genotypes of Helicobacter pylori strains
(Turk J Gastroenterol 2015; 26: 297-303)
DOI: 10.5152/tjg.2015.8058
The relationship of recurrent aphthous stomatitis and Helicobacter pylori, cytokine gene polymorphism and cobalamin
(Turk J Gastroenterol 2015; 26: 304-308)
DOI: 10.5152/tjg.2015.0161
Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux
(Turk J Gastroenterol 2015; 26: 367-372)
DOI: 10.5152/tjg.2015.0110
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 2013; 24: 316-321)
DOI: 10.4318/tjg.2013.0509
Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children
(Turk J Gastroenterol 2013; 24: 382-386)
DOI: 10.4318/tjg.2013.0575
Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients
(Turk J Gastroenterol 2012; 23: 552-559)
DOI: 10.4318/tjg.2012.0410
Does Helicobacter pylori treatment improve the symptoms of globus hystericus?
(Turk J Gastroenterol 2012; 23: 681-685)
DOI: 10.4318/tjg.2012.0507
A study on the protective activity of kefir against gastric ulcer
(Turk J Gastroenterol 2012; 23: 333-338)
DOI: 10.4318/tjg.2012.0343
Effects of probiotics on methionine cholinedeficient diet-induced steatohepatitis in rats
(Turk J Gastroenterol 2012; 23: 110-121)
DOI: 10.4318/tjg.2012.0330
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori
(Turk J Gastroenterol 2012; 23: 8-13)
DOI: 10.4318/tjg.2012.0392
Accuracy of biopsies for Helicobacter pylori in the presence of intestinal metaplasia of the stomach
(Turk J Gastroenterol 2014; 25: 19-23)
DOI: 10.5152/tjg.2014.6476
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease
(Turk J Gastroenterol 2011; 22: 1-5)
DOI: 10.4318/tjg.2011.0148
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance
(Turk J Gastroenterol 2017; 28: 3-11)
DOI: 10.5152/tjg.2016.0278
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection
(Turk J Gastroenterol 2015; 26: 456-460)
DOI: 10.5152/tjg.2015.0233
Distribution of gastric carcinoma in an area with a high prevalence of Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 98-103)
DOI: 10.5152/tjg.2017.17607
Influences of proton pump inhibitor on Helicobacter pylori adherence to the gastrointestinal cell lines
(Turk J Gastroenterol 2017; 28: 53-59)
DOI: 10.5152/tjg.2016.0409
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 13.11.2017